Floatz logo

13 assets in Grade II Glioma

Therapeutic assets addressing Grade II Glioma, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Pamiparib
Grade II Glioma
Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsP1/2B (57)
2 (1H))-QUINOLINONE,6-(AMINO(4-CHLOROPHENYL)(1-METHYL-1H-IMIDAZOL-5-YL)METHYL)-4-(3-CHLOROPHENYL)-1-METHYL-,(+)-
Grade II Glioma
National Cancer Institute (NCI)P2CCC (53)
Ivosidenib
Grade II Glioma
National Cancer Institute (NCI)P2CCC (53)
Olaparib
Grade II Glioma
National Cancer Institute (NCI)P2CCC (53)
Selpercatinib
Grade II Glioma
National Cancer Institute (NCI)P2CCC (53)
Infigratinib
Grade II Glioma
Helsinn Healthcare SAP1/2CC (44)
Arm 1: Il13Ra2-Specific Car Tcm Cells
Grade II Glioma
City of Hope Medical CenterP1CC (43)
Arm 2: Il13Ra2-Specific Car Tcm Cells
Grade II Glioma
City of Hope Medical CenterP1CC (43)
Arm 3: Il13Ra2-Specific Car Tcm Cells
Grade II Glioma
City of Hope Medical CenterP1CC (43)
Arm 4: Il13Ra2-Specific Car Tcm Cells
Grade II Glioma
City of Hope Medical CenterP1CC (43)
Chlorotoxin -Cd28-Cd3Zeta-Cd19T-Expressing Car T-Lymphocytes
Grade II Glioma
City of Hope Medical CenterP1CC (43)
Triapine
Grade II Glioma
Northwestern UniversityP1CC (43)
Ketoconazole
Grade II Glioma
Universitas PadjadjaranEarly P1NR ()